Condition
Gaucher Disease, Type 3 clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Gaucher Disease, Type 3 clinical trials that are recruiting, in United States. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Using magnetic resonance spectroscopy to identify biomarkers in Type 3 Gaucher disease
This study is testing if a special brain scan can help find new markers in adults with Type 3 Gaucher disease that show how well treatments are working and how the disease affects them.
-
In utero enzyme replacement therapy for lysosomal storage disorders
This study is testing whether giving enzyme replacement therapy to unborn babies with lysosomal storage disorders can improve their health and development before they are born.
Related topics
Quick answers
How many Gaucher Disease, Type 3 clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in United States. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.